Journal of the American Chemical Society
ARTICLE
was then dissolved in anhydrous CH2Cl2 (5 mL) and treated with 2-
cyanoetoxy-bis-(N,N-diisopropylamino)phosphine (530 μL, 1.7 mmol).
The reaction mixture was stirred for 3 h under argon at room tempera-
ture. Next, the mixture was poured into a degassed saturated NaHCO3
solution and extracted three times with degassed CH2Cl2. The combined
organic layers were dried over Na2SO4, and the solvent was removed
under reduced pressure. The crude material was purified by short column
chromatography on deactivated silica gel (1% Et3N). The product
was eluted with cyclohexane/AcOEt (5:7) and was obtained as a slightly
beige foam. Yield: 83%. 1H NMR (300 MHz, CDCl3, both diastereomers):
δ = 1.01-1.25 (m, 12H, 2 ꢀ CH(CH3)2,) 2.34-2.61 (m, 4H, CH2CN,
20-H), 3.32-3.82 (m, 12H, 50-H OCH2, 2 ꢀ i-Pr-CH, 2 ꢀ OCH3),
3.87-3.91 (m, 1H, 40-H), 4.14 (m, 2H, 9-H), 4.57-4.59 (m, 1H, 30-H),
CH(CH3)2), 2.77 (t, 3J = 5.8 Hz, 1H,CH2-CN), 2.88 (t, 3J = 5.8 Hz, 1H,
CH2-CN), 3.48-3.61 (m, 2H, CH(CH3)2), 3.74 (s, 6H, OCH3), 3.97 (t,
3J = 5.7 Hz, 2H, OCH2), 4.16-4.22 (m, 2H, H-40, H-30), 4.49-4.56 (m,
1H, H-20), 5.78 (d, 3J = 5.7 Hz, 1H, H-10), 5.84 (d, 3J = 6.3 Hz, 1H, H-10),
6.87-6.92 (m, 4H, ar), 7.27-7.43 (m, 9H, ar), 7.99, 8.01 (2s, 1H, H-6),
9.97-9.99 (m, 1H, NH), 11.75 (br s, 1H, NH). 31P NMR (300 MHz,
[d6]DMSO, 25 ꢀC, δP of H3PO4 at 0.0 ppm as the external reference): δ
(ppm) = 148.24, 149.27.
5-(3-Trifluoroacetamidopropenyl)-uridine. 5-Iodoridine (740 mg,
2 mmol) was dissolved in 7 mL of DMF. To the resulting solution were
added sodium acetate buffer (7.1 mL, 0.1 M, pH 5.2) and N-allyltrifluo-
roacetamide (2 mL, 17 mmol). A solution of Na2[PdCl4] (658 mg,
2.2 mmol) in DMF (7 mL) was added while stirring vigorously. The reac-
tion flask was placed in an oil bath at 80 ꢀC for 8 h. The precipitated
palladium was filtered off through Celite. The filtrate was concentrated in
vacuo to a viscous brown oil. The crude product was purified by column
chromatography (dichloromethane/methanol 98:2) to obtain a white
powder. Yield: 58%. 1H NMR (300 MHz, [d6]DMSO, 25 ꢀC, δH of the
solvent at 2.5 ppm as internal reference): δ (ppm) = 3.55-3.70 (m, 2H,
H-50, H-500), 3.82-3.89 (m, 3H, CH2, H-40), 3.99 (1H, br s, H-30), 4.07
(m, 1H, H-20), 5.09 (br s, 1H, OH), 5.22 (br s, 1H, OH), 5.41 (d, 1H,
OH), 5.77 (d, 3J = 4.8 Hz, 1H, H-10), 6.18 (d, 2J = 15.9 Hz, 1H, dCH),
6.46 (tt, 2J = 15.9 Hz, 3J = 6.1 Hz, 1H, dCH), 8.12 (s, 1H, H-6), 9.69 (t,
3J = 5.4 Hz, 1H, NH). 13C NMR (300 MHz, [d6]DMSO, 25 ꢀC, δC of the
solvent at 39.61 ppm as internal reference): δ (ppm) = 41.59, 60.51,
3
6.34 (t, J = 6.6 Hz, 1H, 10-H), 6.76-6.91 (m, 4H, ar.), 7.61-7.70 m,
9H, ar.), 8.21, 8.22 (2 ꢀ s, 1H, 6-H). 31P NMR (120 MHz, CDCl3)
δ = 149.1, 150.0. MS (ESI): m/z (%) = 303.2 (14) [DMTþ], 901.9 (100)
[M þ 22þ].
5-(3-Trifluoroacetamidopropargyl)-50-O-dimethoxytrityl-20-O-tert-
butyldimethylsilyl Uridine. 5-Iodoridine was 50-O-tritylated and 20-O-
silylated according to standard procedures described in the literature.42,43
5-Iodo-50-O-dimethoxytrityl-20-O-tert-butyldimethylsilyl-uridine (300 mg,
0.38 mmol) was dissolved in 3.0 mL of DMF, and 228 μL of freshly
distilled triethylamine was added. N-Propargyltrifluoroacetamide (182 mg,
1.1 mmol), Pd(PPh3)4 (44.0 mg, 0.066 mmol), and Cu(I)iodide (14.4 mg,
0.076 mmol) were added to the solution. The reaction mixture was stirred
for 8 h in the dark at room temperature, concentrated in vacuo, and a solu-
tion of 5% Na2EDTA was added to the residue. The crude product was
extracted with ethyl acetate (3 ꢀ 20 mL). The combined organic layers
were collected, dried over Na2SO4, and concentrated in vacuo. The crude
product was purified by column chromatography (hexane/ethylacetate
70: 30) to give 50-O-(4,40-dimethoxytrityl)-20-O-tert-butyldimethylsilyl-5-
(3-trifluoroacetamidoprop-1-ynyl)uridine as a pale yellow solid. Yield:
66%. 1HNMR(300 MHz, [d6]DMSO, 25ꢀC, δH of the solvent at 2.5 ppm
as internal reference): δ (ppm) = 0.03, 0.05 (2s, 6H, Si(CH3)2), 0.88
(s, 9H, C(CH3)3), 3.08, (2s, 2H, H-50, H-500), 3.74 (s, 6H, 2 ꢀ OCH3),
3.93 (d, 3J = 5.4 Hz, 2H, N-CH2), 4.01-4.09 (m, 2H, H-40, H-30), 4.34
(t, 3J = 4.6 Hz, 1H, H-20), 5.17 (d, 3J = 6.0 Hz, 1H, OH-30), 5.74 (d, 3J =
5.7 Hz, 1H, H-10), 6.89 (dd, 2J = 9.0 Hz, 3J = 3.3 Hz, 4H,ar), 7.23-7.43
2
69.51, 73.73, 84.75, 88.13, 109.86, 115.97 (quart, J = 288 Hz, CF3),
123.92, 124.23, 138.20, 149.90, 156.06 (quart, 3J = 36 Hz, (CdO)CF3),
162.25.
5-[3-(6-Trifluoroacetylamidohexanamido)propenyl]uridine. 5-Iodor-
idine (740 mg, 2 mmol) was dissolved in 7 mL of DMF. NaOAc buffer (7.1
mL, 0.1 M, pH 5.2) and N-allyl-6-(N-trifluoroacetylamido)hexanamide
(3.85 g, 14mmol) wereaddedtothesolution, andamixtureof Na2[PdCl4]
(172 mg, 0.59 mmol) in DMF (2.5 mL) was added while stirring vigo-
rously. The reaction flask was placed in an oil bath at 83 ꢀC. After 2 h,
another portion of Na2[PdCl4] was added. After 8 h, the precipitated
palladium was filtered off through Celite. NaBH4 (2 ꢀ 12 mg) was added
to the filtrate while vigorously stirring. The resulting yellowish solution was
filtered through Celite, and the solvents were evaporated to give a viscous
yellow oil. The crude product was purified by column chromatography,
giving a white solid. Yield: 50%. 1H NMR (300 MHz, [d6]DMSO, 25 ꢀC,
δH of the solvent at 2.5 ppm as internal reference): δ (ppm) = 1.20-1.31
(m, 2H, CH2), 1.42-1.55 (m, 4H, CH2-CH2), 2.09 (t, 3J = 7.4 Hz, 2H,
CH2), 3.13-3.19 (m, 2H, CH2), 3.54-3.60 (m, 2H, H50, H500), 3.74 (t,
3J = 5.4 Hz, 2H, CH2), 3.82-3.87 (m, 1H, H40), 3.99 (q, 3J = 4.7 Hz, 1H,
H-30), 4.04-4.09 (m, 1H, H-20),5.07(d,3J= 5.1 Hz, 1H, OH),5.2(t,3J=4.8
Hz, 1H, OH), 5.39 (d, 3J = 5.5 Hz, 1H, OH), 5.78 (d, 3J = 4.9 Hz, 1H, H-10),
6.12 (d, 2J = 16.0 Hz, 1H, dCH), 6.40 (tt, 2J = 15.9 Hz, 3J = 5.8, 1H, dCH),
7.96 (t, 3J = 5.6 Hz, 1H, NH), 8.08 (s, 1H, H-6), 9.39 (br s, 1H, NH), 11.42
(br s, 1H, NH). 13C NMR (300 MHz, [d6]DMSO, 25 ꢀC, δC of the solvent
at 39.61 ppm as internal reference): δ (ppm) = 25.11, 25.79, 28.04, 35.06,
3
(m, 9H,ar), 7.97 (s, 1H, H-60), 9.97 (t, J = 5.4 Hz, 1H, N-H), 11.74
(s, 1H, N-H). 13C NMR (300 MHz, [d6]DMSO, 25 ꢀC, δC of the solvent
at 39.61ppmasinternalreference):δ(ppm) =-5.14, -4.78, 17.92, 25.63,
29.31, 55.00, 59.75, 63.03, 69.62, 74.87, 75.56, 83.28, 85.92, 87.41, 88.86,
98.08, 113.22, 113.30, 115.76 (quart, 2J = 289 Hz, CF3), 126.65, 127.42,
127.93, 129.67, 129.73, 134.96, 135.54, 143.34, 144.84, 149.46, 155.93
(quart, 3J = 37 Hz, (CdO)CF3), 158.1, 161.41.
5-(3-Trifluoroacetamidopropargyl)-50-O-dimethoxytrityl-20-O-tert-
butyldimethylsilyl-uridine-30-[(2-cyanoethyl)-N,N0-diisopropylamino-
phosphoramidite] (Figure 1, C). 5-(3-Trifluoroacetamidopropargyl)-50-O-
dimethoxytrityl-20-O-tert-butyldimethylsilyl uridine (296 mg, 0.36 mmol)
was coevaporated with 5 mL of dichloromethane containing 10% pyridine.
The nucleoside was kept under vacuum overnight. Dry ethyl diisopropyl
amine (0.32 mL, 4 ꢀ 0.36 mmol, freshly distilled just before use) was
added, followed by 2 mL of dry dichloromethane. 2-Cyanoethyl-N,N0-
diisopropylamino-chlorophosphoramidite (0.12 mL, 1.5 ꢀ 0.36 mmol)
was added dropwise to the solution. After 3 h, 0.2 mL of dry methanol was
added. The reaction mixture was diluted with 150 mL of ethyl acetate
containing 10% triethylamine, washed with a saturated solution of Na2CO3
(1 ꢀ 10 mL), and with a saturated solution of potassium chloride (1 ꢀ
10 mL), dried over Na2SO4, and concentrated in vacuo. After purification
byshort column chromatography (hexane/ethylacetate/triethylamine 60:
30:10), the product was obtained as a pale yellow foam. Yield: 80%. 1H
NMR (300 MHz, [d6]DMSO, 25 ꢀC, δH of the solvent at 2.5 ppm as inter-
nal reference, both diastereomers): δ (ppm) = 0.01, 0.03, 0.05, 0.09 (4s,
12H, Si-CH3), 0.83, 0.86 (2s, 18H, C(CH3)3), 1.18-1.53 (m, 12H,
2
40.80, 43.20, 60.55, 69.57, 73.68, 84.75, 88.04, 110.32, 115.95 (quart, J =
3
289 Hz, CF3), 122.09, 126.90, 137.34, 149.79, 156.10 (quart, J = 36 Hz,
(CdO)CF3), 162.06, 171.69.
Both compounds, 5-(3-trifluoroacetamidopropenyl)uridine and 5-
[3-(6-trifluoroacetyl-aminohexanamido)propenyl)uridine, were 50-O-
dimethoxytritylated and 20-O-silylated with TBDMSCl according to
standard protocols.42,43
5-(3-Trifluoroacetamidopropenyl-50-O-dimethoxytrityl-20-O-tert-
butyldimethylsilyl-uridine-30-[(2-cyanoethyl)-N,N0-diisopropylamin-
ophosphoramidite] (Figure 1, B). 5-(3-Trifluoroacetamidopropenyl)-50-O-
dimethoxytrityl-20-O-tert-butyldimethylsilyluridine (243 mg, 0.3 mmol) was
coevaporated with dichloromethane (3 ꢀ 5 mL) containing 10% pyri-
dine. The nucleoside was kept under vacuum overnight. Dry ethyl diiso-
propyl amine (0.27 mL, 1.2 mmol, freshly distilled over CaH2 just before
2466
dx.doi.org/10.1021/ja105725e |J. Am. Chem. Soc. 2011, 133, 2463–2480